Fujimasa Tada Selected Research

Overweight

3/2024

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fujimasa Tada Research Topics

Disease

45	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2012
7	Liver Neoplasms (Liver Cancer) 05/2024 - 12/2022
4	Neoplasms (Cancer) 12/2023 - 11/2012
4	Non-alcoholic Fatty Liver Disease 01/2023 - 03/2013
4	Infections 12/2020 - 03/2016
4	Insulin Resistance 06/2013 - 10/2011
3	Chronic Hepatitis C 02/2024 - 02/2019
3	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2023
3	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Hemorrhage 04/2024 - 11/2023
2	Thrombosis (Thrombus) 08/2023 - 01/2007
2	Alcoholic Fatty Liver 01/2023 - 08/2017
2	Fatigue 01/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 03/2013
1	Varicose Veins (Varicose Vein) 04/2024
1	Overweight 03/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Esophageal and Gastric Varices (Esophageal Varices) 11/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2023
1	Kidney Neoplasms (Kidney Cancer) 08/2023
1	Fatty Liver 02/2023
1	Proteinuria 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Portal Hypertension 07/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2021
1	Virus Diseases (Viral Diseases) 02/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Disease Progression 08/2017
1	Chronic Hepatitis B 03/2016
1	Chemical and Drug Induced Liver Injury 01/2015
1	Erythema 01/2015
1	Abdominal Pain (Pain, Abdominal) 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Rupture 01/2015
1	Coinfection 01/2014
1	Obesity 03/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2013

Drug/Important Bio-Agent (IBA)

25	atezolizumabIBA 05/2024 - 01/2022
25	Bevacizumab (Avastin)FDA Link 05/2024 - 01/2022
15	lenvatinibIBA 04/2024 - 01/2023
8	AlbuminsIBA 05/2024 - 01/2023
7	BilirubinIBA 05/2024 - 01/2023
6	Antiviral Agents (Antivirals)IBA 04/2024 - 02/2019
4	B-Cell Activating FactorIBA 06/2013 - 10/2011
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 08/2023
2	Fetal Proteins (Fetoprotein)IBA 05/2024 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	Ribavirin (Virazole)FDA LinkGeneric 02/2019 - 01/2017
2	SofosbuvirIBA 02/2019 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2015
2	AntigensIBA 01/2014 - 11/2012
2	AdipokinesIBA 03/2013 - 10/2011
1	Serum AlbuminIBA 10/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	acarboxyprothrombin (PIVKA)IBA 08/2023
1	IronIBA 08/2023
1	CopperIBA 08/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2023
1	Proton Pump InhibitorsIBA 08/2023
1	RamucirumabIBA 02/2023
1	C-Reactive ProteinIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Therapeutic UsesIBA 11/2022
1	Monoclonal AntibodiesIBA 01/2022
1	CreatinineIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	asunaprevirIBA 02/2019
1	daclatasvirIBA 02/2019
1	ledipasvirIBA 02/2019
1	ipragliflozinIBA 01/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Sodium-Glucose Transport ProteinsIBA 01/2018
1	Palmitic AcidsIBA 08/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 08/2017
1	NucleosidesIBA 03/2016
1	entecavir FDA Link 03/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2015
1	IodineIBA 01/2015
1	Carbon DioxideIBA 01/2015
1	Nonprescription Drugs (Patent Medicines)IBA 01/2015
1	Contrast MediaIBA 01/2015
1	Tenofovir (Viread)FDA Link 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2013
1	Immunoglobulin G (IgG)IBA 03/2013
1	VaccinesIBA 11/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2012
1	Insulin (Novolin)FDA Link 10/2011
1	B-Cell Activation Factor ReceptorIBA 10/2011

Therapy/Procedure

20	Therapeutics 05/2024 - 01/2007
5	Radiofrequency Ablation 03/2024 - 11/2022
1	Catheters 10/2023
1	Aftercare (After-Treatment) 06/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2014
1	Immunotherapy 11/2012